The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia
Open accessAbstract
Cognitive deficits represent a significant characteristic of schizophrenia. However, a majority of the clinical studies have been conducted in antipsychotic drug treated patients. Thus, it remains unclear if significant cognitive impairments exist in the absence of medication. This is the first meta-analysis of cognitive findings in drug-naïve patients with schizophrenia. Cognitive data from 23 studies encompassing 1106 patients and 1385 controls published from 1992 to 2013 were included. Tests were to a large extent ordered in cognitive domains according to the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery. Analysis was performed with STATA using the random-effects model and heterogeneity as well as Egger's publication bias was assessed. Overall the results show that patients performed worse than healthy controls in all cognitive domains with medium to large effect sizes. Verbal memory, speed of processing and working memory were three of the domains with the greatest impairments. The pattern of results is in line with previous meta-analytic findings in antipsychotic treated patients. The present meta-analysis confirms the existence of significant cognitive impairments at the early stage of the illness in the absence of antipsychotic medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., Essock, S., Fenton, W. S., Frese, F. J., Gold, J. M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010042 · Cited by 2,342
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,419
Self-citationNeuropsychological Function in Schizophrenia: Selective Impairment in Memory and Learning
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,155
Neurocognition in first-episode schizophrenia: a meta-analytic review.
Mesholam-Gately, R. I., Giuliano, A. J., Goff, K. P., Faraone, S. V., & Seidman, L. J. (2009) · Neuropsychology · doi:10.1037/a0014708 · Cited by 1,130 · cited 6×
“Approximately 37% of the patients in the Mesholam-Gately et al. (2009) study were either in a medication free or drug naïve state, and twelve of the studies (corresponding to approximately 18% of the patients) included only drug-naïve patients, some of which may have been included also in the…”
BackgroundMethodResultInfluentialMemory Impairment in Schizophrenia: A Meta-Analysis
Aleman, A., Hijman, R., de Haan, E. H. F., & Kahn, R. S. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1358 · Cited by 1,092
Keefe, R. S. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.633 · Cited by 1,065
Andreasen, N. C. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120031006 · Cited by 885
Dickinson, D., Ramsey, M. E., & Gold, J. M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.532 · Cited by 863 · cited 2×
“…speed of processing relative to other cognitive domains are in line with previous meta-analyses on studies where most patients were medicated and had been ill for several years (Saykin et al., 1991; Heinrichs and Zakzanis, 1998; Aleman et al., 1999; Dickinson et al., 2007; Schaefer et al., 2013).”
Result(1998) · PubMed · doi:10.1176/ajp.155.3.344 · Cited by 784
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
Kern, R. S., Nuechterlein, K. H., Green, M. F., Baade, L. E., Fenton, W. S., Gold, J. M., Keefe, R. S. E., Mesholam-Gately, R., Mintz, J., Seidman, L. J., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010043 · Cited by 744
Snitz, B. E. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi048 · Cited by 714
Selective Deficits in Prefrontal Cortex Function in Medication-Naive Patients With Schizophrenia
Barch, D. M., Carter, C. S., Braver, T. S., Sabb, F. W., MacDonald, A., Noll, D. C., & Cohen, J. D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.3.280 · Cited by 614
The global cognitive impairment in schizophrenia: consistent over decades and around the world
Schaefer, J., Giangrande, E., Weinberger, D. R., & Dickinson, D. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.009 · Cited by 605
Bora, E., & Murray, R. M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt085 · Cited by 507
Age-Related Cognitive Deficits Mediated by Changes in the Striatal Dopamine System
Bäckman, L., Ginovart, N., Dixon, R. A., Wahlin, T.-B. R., Wahlin, Å., Halldin, C., & Farde, L. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.4.635 · Cited by 473
Self-citationCognitive deficits in relatives of patients with schizophrenia: a meta-analysis
Sitskoorn, M. M., Aleman, A., Ebisch, S. J. H., Appels, M. C. M., & Kahn, R. S. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.007 · Cited by 444
Memory and frontal lobe function.
Shimamura, A. P. (1995) · Cited by 423
Frontostriatal Disorder of Cerebral Metabolism in Never-Medicated Schizophrenics
Buchsbaum, M. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120023005 · Cited by 324
Bora, E., Lin, A., Wood, S. J., Yung, A. R., McGorry, P. D., & Pantelis, C. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12261 · Cited by 294
Molecular Imaging of the Dopaminergic System and its Association with Human Cognitive Function
Cropley, V. L., Fujita, M., Innis, R. B., & Nathan, P. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.004 · Cited by 283
Keefe, R. S. E., Sweeney, J. A., Gu, H., Hamer, R. M., Perkins, D. O., McEvoy, J. P., & Lieberman, J. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1061 · Cited by 276
Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia
Cleghorn, J. M., Garnett, E. S., Nahmias, C., Firnau, G., Brown, G. M., Kaplan, R., Szechtman, H., & Szechtman, B. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90040-1 · Cited by 197
Salgado-Pineda, P., Baeza, I., Pérez-Gómez, M., Vendrell, P., Junqué, C., Bargalló, N., & Bernardo, M. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00094-6 · Cited by 177
Neuropsychological function in schizophrenia
Nyman, H. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)80803-3 · Cited by 166
Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis
Szöke, A., Schürhoff, F., Mathieu, F., Méary, A., Ionescu, Ș., & Leboyer, M. (2004) · Psychological Medicine · doi:10.1017/s0033291704003460 · Cited by 138
He, Z., Deng, W., Li, M., Chen, Z., Jiang, L., Wang, Q., Huang, C., Collier, D. A., Gong, Q., Ma, X., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712001638 · Cited by 132
Specific executive dysfunction in patients with first-episode medication-naïve schizophrenia
Chan, R. C. K., Chen, E. Y. H., & Law, C. W. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.09.020 · Cited by 121
Hill, S. K., Beers, S. R., Kmiec, J. A., Keshavan, M. S., & Sweeney, J. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00125-7 · Cited by 120
Zhang, X. Y., Chen, D. C., Xiu, M. H., Yang, F. D., Haile, C. N., Kosten, T. A., & Kosten, T. R. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07422 · Cited by 117
Ramaekers, J. G., Louwerens, J. W., Muntjewerff, N. D., Millius, H., de Bie, A., Rosenzweig, P., Patat, A. A., & O’Hanlon, J. F. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00003 · Cited by 105
Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood
Saeedi, H., Remington, G., & Christensen, B. K. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.03.033 · Cited by 102
Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus
Takahashi, H., Kato, M., Hayashi, M., Okubo, Y., Takano, A., Ito, H., & Suhara, T. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.11.008 · Cited by 102
Parellada, E., Catafau, A. M., Bernardo, M., Lomeña, F., González-Monclús, E., & Setoain, J. (1994) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(94)90021-3 · Cited by 88
Neuropsychological Functioning in First-Break, Never-Medicated Adolescents With Psychosis
Brickman, A. M., Buchsbaum, M. S., Bloom, R. F., Bokhoven, P., Paul-Odouard, R., Haznedar, M. M., Dahlman, K. L., Hazlett, E. A., Aronowitz, J., Heath, D., et al. (2004) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000138229.29157.3e · Cited by 83
Červenka, S., Bäckman, L., Cselényi, Z., Halldin, C., & Farde, L. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.063 · Cited by 80
Self-citationLu, W., Zhang, C., Yi, Z., Li, Z., Wu, Z., & Fang, Y. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9750-4 · Cited by 78
Vernaleken, I., Kumakura, Y., Cumming, P. D., Buchholz, H., Siessmeier, T., Stoeter, P., Müller, M. J., Bartenstein, P., & Gründer, G. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.11.014 · Cited by 76
Wang, Q., Chan, R. C. K., Sun, J., Yao, J., Deng, W., Sun, X., Liu, X., Sham, P. C., Ma, X., Meng, H., et al. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.08.030 · Cited by 73
van Veelen, N. M. J., Vink, M., Ramsey, N. F., van Buuren, M., Bas‐Hoogendam, J. M., & Kahn, R. S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.026 · Cited by 62
Fagerlund, B., Mackeprang, T., Gade, A., Hemmingsen, R., & Glenthoj, B. Y. (2004) · CNS Spectrums · doi:10.1017/s1092852900009354 · Cited by 55
Modeling cholinergic aspects of schizophrenia: Focus on the antimuscarinic syndrome
Barak, S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.006 · Cited by 50
JONES, H. M., Brammer, M. J., O’Toole, M., Taylor, T., Ohlsen, R. I., Brown, R. G., Purvis, R., Williams, S., & Pilowsky, L. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.006 · Cited by 47
Andersen, R., Fagerlund, B., Rasmussen, H., Ebdrup, B. H., Aggernæs, B., Gade, A., Oranje, B., & Glenthoj, B. Y. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2012.06.003 · Cited by 46
Effects of antipsychotic treatment on cognition in healthy subjects
Veselinović, T., Schorn, H., Vernaleken, I., Hiemke, C., Zernig, G., Gur, R. C., & Gründer, G. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112466183 · Cited by 35
Dysfunction of dorsolateral prefrontal cortex in antipsychotic-naïve schizophreniform psychosis
Harrison, B. J., Yücel, M., Shaw, M. E., Brewer, W. J., Nathan, P. J., Strother, S. C., Olver, J. S., Egan, G. F., Velakoulis, D., McGorry, P. D., et al. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.02.006 · Cited by 34
Hu, M., Chen, J., Li, L., Zheng, Y., Wang, J., Guo, X., Wu, R., & Zhao, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.037 · Cited by 33
Effects of risperidone on information processing and attention in first-episode schizophrenia
Hong, K. S., Kim, J., Koh, H. J., Koo, M. S., Kim, J., Lee, D. G., & Kim, E. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00167-0 · Cited by 33
Oculomotor and Neuropsychological Effects of Antipsychotic Treatment for Schizophrenia
Hill, S. K., Reilly, J. L., Harris, M. S. H., Khine, T. T., & Sweeney, J. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm112 · Cited by 31
Andersen, R., Fagerlund, B., Rasmussen, H., Ebdrup, B. H., Aggernæs, B., Gade, A., Oranje, B., & Glenthoj, B. Y. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.10.013 · Cited by 20
Cited by
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
McCutcheon, R. A., Keefe, R. S. E., & McGuire, P. K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01949-9 · Cited by 741
Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective
Sheffield, J. M., Karcher, N. R., & Barch, D. M. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9388-2 · Cited by 457
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
Carvalho, A. F., Bortolato, B., Miskowiak, K., Vieta, E., & Köhler, C. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s76700 · Cited by 306
Velikonja, T., Fett, A.-K., & Velthorst, E. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3645 · Cited by 292
The C factor: cognitive dysfunction as a transdiagnostic dimension in psychopathology
Abramovitch, A., Short, T., & Schweiger, A. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102007 · Cited by 269
Metadata
- Authors
- Fatouros-Bergman, H., Cervenka, S., Flyckt, L., Edman, G., & Farde, L.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 158
- Issue
- 1-3
- Pages
- 156-162
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2024078112
- Cited by
- 273
- References
- 55
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.